Crispr Therapeutics shares owned by Mercer Global Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mercer Global Advisors
from 13F filings
Historical chart of Mercer Global Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Mercer Global Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $691k | 11k | 62.61 |
| 2023-09-30 | $499k | 11k | 45.43 |
| 2023-06-30 | $595k | 11k | 56.19 |
| 2023-03-31 | $573k | 13k | 45.20 |
| 2022-12-31 | $503k | 12k | 40.66 |
| 2022-09-30 | $799k | 12k | 65.32 |
| 2022-06-30 | $800k | 13k | 60.82 |
| 2022-03-31 | $840k | 13k | 62.74 |
| 2021-12-31 | $370k | 4.9k | 75.68 |
| 2021-09-30 | $467k | 4.2k | 111.86 |
| 2021-06-30 | $537k | 3.3k | 161.75 |
| 2021-03-31 | $359k | 2.9k | 121.78 |
| 2020-12-31 | $393k | 2.6k | 153.22 |